• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活素A:一种新型的树突状细胞衍生细胞因子,可有效减弱CD40配体特异性细胞因子和趋化因子的产生。

Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production.

作者信息

Robson Neil C, Phillips David J, McAlpine Tristan, Shin Amanda, Svobodova Suzanne, Toy Tracey, Pillay Vinochani, Kirkpatrick Naomi, Zanker Damien, Wilson Kathy, Helling Imke, Wei Heng, Chen Weisan, Cebon Jonathan, Maraskovsky Eugene

机构信息

Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Heidelberg, Victoria 3084, Australia.

出版信息

Blood. 2008 Mar 1;111(5):2733-43. doi: 10.1182/blood-2007-03-080994. Epub 2007 Dec 21.

DOI:10.1182/blood-2007-03-080994
PMID:18156495
Abstract

Activin-A is a transforming growth factor-beta (TGF-beta) superfamily member that plays a pivotal role in many developmental and reproductive processes. It is also involved in neuroprotection, apoptosis of tumor and some immune cells, wound healing, and cancer. Its role as an immune-regulating protein has not previously been described. Here we demonstrate for the first time that activin-A has potent autocrine effects on the capacity of human dendritic cells (DCs) to stimulate immune responses. Human monocyte-derived DCs (MoDCs) and the CD1c(+) and CD123(+) peripheral blood DC populations express both activin-A and the type I and II activin receptors. Furthermore, MoDCs and CD1c(+) myeloid DCs rapidly secrete high levels of activin-A after exposure to bacteria, specific toll-like receptor (TLR) ligands, or CD40 ligand (CD40L). Blocking autocrine activin-A signaling in DCs using its antagonist, follistatin, enhanced DC cytokine (IL-6, IL-10, IL-12p70, and tumor necrosis factor-alpha [TNF-alpha]) and chemokine (IL-8, IP-10, RANTES, and MCP-1) production during CD40L stimulation, but not TLR-4 ligation. Moreover, antagonizing DC-derived activin-A resulted in significantly enhanced expansion of viral antigen-specific effector CD8(+) T cells. These findings establish an immune-regulatory role for activin-A in DCs, highlighting the potential of antagonizing activin-A signaling in vivo to enhance vaccine immunogenicity.

摘要

激活素A是转化生长因子-β(TGF-β)超家族成员,在许多发育和生殖过程中起关键作用。它还参与神经保护、肿瘤及某些免疫细胞的凋亡、伤口愈合和癌症。此前尚未描述其作为免疫调节蛋白的作用。在此,我们首次证明激活素A对人树突状细胞(DC)刺激免疫反应的能力具有强大的自分泌作用。人单核细胞衍生的DC(MoDC)以及CD1c(+)和CD123(+)外周血DC群体均表达激活素A以及I型和II型激活素受体。此外,MoDC和CD1c(+)髓样DC在暴露于细菌、特异性Toll样受体(TLR)配体或CD40配体(CD40L)后会迅速分泌高水平的激活素A。使用其拮抗剂卵泡抑素阻断DC中的自分泌激活素A信号,可增强CD40L刺激期间DC细胞因子(IL-6、IL-10、IL-12p70和肿瘤坏死因子-α [TNF-α])和趋化因子(IL-8、IP-10、RANTES和MCP-1)的产生,但不影响TLR-4连接。此外,拮抗DC衍生的激活素A可显著增强病毒抗原特异性效应CD8(+) T细胞的扩增。这些发现确立了激活素A在DC中的免疫调节作用,突出了在体内拮抗激活素A信号以增强疫苗免疫原性的潜力。

相似文献

1
Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production.激活素A:一种新型的树突状细胞衍生细胞因子,可有效减弱CD40配体特异性细胞因子和趋化因子的产生。
Blood. 2008 Mar 1;111(5):2733-43. doi: 10.1182/blood-2007-03-080994. Epub 2007 Dec 21.
2
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation.老年树突状细胞对 LPS/IFN-γ 和 CD40L 刺激的反应尽管不成熟。
PLoS One. 2018 Apr 13;13(4):e0195313. doi: 10.1371/journal.pone.0195313. eCollection 2018.
3
Mechanism of chimeric vaccine stimulation of indoleamine 2,3-dioxygenase biosynthesis in human dendritic cells is independent of TGF-β signaling.嵌合疫苗刺激人树突状细胞中吲哚胺2,3-双加氧酶生物合成的机制独立于转化生长因子-β信号传导。
Cell Immunol. 2017 Sep;319:43-52. doi: 10.1016/j.cellimm.2017.08.002. Epub 2017 Aug 21.
4
Activin-A attenuates several human natural killer cell functions.激活素A可减弱几种人类自然杀伤细胞的功能。
Blood. 2009 Apr 2;113(14):3218-25. doi: 10.1182/blood-2008-07-166926. Epub 2009 Jan 13.
5
IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.白细胞介素-21增强人单核细胞衍生树突状细胞中细胞因子信号转导抑制因子(SOCS)基因的表达,并抑制脂多糖诱导的细胞因子产生。
J Leukoc Biol. 2006 Jun;79(6):1279-85. doi: 10.1189/jlb.0905503. Epub 2006 Mar 21.
6
Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.肿瘤坏死因子(TNF)家族成员CD40配体、核因子κB受体活化因子配体和TNF-α在HIV-1感染和未感染个体中树突状细胞激活及病毒特异性CD8 + T细胞记忆反应扩增中的协同作用。
J Immunol. 2003 Feb 15;170(4):1797-805. doi: 10.4049/jimmunol.170.4.1797.
7
Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.通过腺病毒介导的hCD40L基因与γ干扰素共转染,生成同时分泌白细胞介素-12并具有迁移能力的人树突状细胞。
J Immunother. 2009 Jun;32(5):524-38. doi: 10.1097/CJI.0b013e3181a28422.
8
Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs.在前列腺素E2存在的情况下,人单核细胞衍生树突状细胞(MoDCs)的成熟优化了CD4和CD8 T细胞介导的对蛋白质抗原的反应:PGE2在MoDCs趋化因子和细胞因子表达中的作用
Int Immunol. 2005 Dec;17(12):1561-72. doi: 10.1093/intimm/dxh335. Epub 2005 Nov 22.
9
IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation.白细胞介素-1β增强人树突状细胞(DC)中CD40配体介导的细胞因子分泌:一种不依赖T细胞的DC激活机制。
J Immunol. 2002 Jan 15;168(2):713-22. doi: 10.4049/jimmunol.168.2.713.
10
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli.体内由Flt3配体产生的树突状细胞与体外由血液单核细胞产生的树突状细胞的功能比较:特定种类生理刺激对功能的差异调节
Blood. 2003 Sep 1;102(5):1753-63. doi: 10.1182/blood-2002-12-3854. Epub 2003 May 8.

引用本文的文献

1
Molecular mechanisms and clinicopathological characteristics of inhibin βA in thyroid cancer metastasis.抑素βA 在甲状腺癌转移中的分子机制及临床病理特征。
Int J Mol Med. 2024 Nov;54(5). doi: 10.3892/ijmm.2024.5423. Epub 2024 Sep 20.
2
INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling.抑制素βA通过抑制γ干扰素信号通路促进肿瘤生长并诱导对程序性死亡受体配体1阻断的抗性。
Acta Pharmacol Sin. 2025 Feb;46(2):448-461. doi: 10.1038/s41401-024-01381-x. Epub 2024 Sep 2.
3
Neutrophil-derived Activin-A moderates their pro-NETotic activity and attenuates collateral tissue damage caused by Influenza A virus infection.
中性粒细胞衍生的激活素 A 调节其促 NETosis 活性,并减轻甲型流感病毒感染引起的旁分泌组织损伤。
Front Immunol. 2024 Feb 26;15:1302489. doi: 10.3389/fimmu.2024.1302489. eCollection 2024.
4
INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer.INHBA(+)癌症相关成纤维细胞在卵巢癌中产生免疫抑制性肿瘤微环境。
NPJ Precis Oncol. 2024 Feb 15;8(1):35. doi: 10.1038/s41698-024-00523-y.
5
Inhibition of anti-tumor immunity by melanoma cell-derived Activin-A depends on STING.黑色素瘤细胞衍生的激活素A对抗肿瘤免疫的抑制作用依赖于干扰素基因刺激蛋白。
Front Immunol. 2024 Jan 18;14:1335207. doi: 10.3389/fimmu.2023.1335207. eCollection 2023.
6
Intricacies of TGF-β signaling in Treg and Th17 cell biology.TGF-β 信号在调节性 T 细胞和 Th17 细胞生物学中的复杂性。
Cell Mol Immunol. 2023 Sep;20(9):1002-1022. doi: 10.1038/s41423-023-01036-7. Epub 2023 May 23.
7
Evolving roles of activins and inhibins in ovarian cancer pathophysiology.激活素和抑制素在卵巢癌病理生理学中的作用演变。
Am J Physiol Cell Physiol. 2023 Feb 1;324(2):C428-C437. doi: 10.1152/ajpcell.00178.2022. Epub 2023 Jan 9.
8
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance.骨形态发生蛋白、激活素、生长分化因子在肿瘤免疫和免疫治疗耐药中的作用。
Front Immunol. 2022 Oct 24;13:1033642. doi: 10.3389/fimmu.2022.1033642. eCollection 2022.
9
Different Immunoregulation Roles of Activin A Compared With TGF-β.与 TGF-β 相比,激活素 A 的不同免疫调节作用。
Front Immunol. 2022 Jun 14;13:921366. doi: 10.3389/fimmu.2022.921366. eCollection 2022.
10
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.激活素 A 可损害黑色素瘤患者 CD8 T 细胞介导的免疫和免疫检查点治疗反应。
J Immunother Cancer. 2022 May;10(5). doi: 10.1136/jitc-2022-004533.